PREDICTING CREATININE CLEARANCE AND RENAL DRUG CLEARANCE IN OBESE PATIENTS FROM ESTIMATED FAT-FREE BODY-MASS

被引：201

作者：

SALAZAR, DE

CORCORAN, GB

机构：

[1] UNIV NEW MEXICO,COLL PHARM,ALBUQUERQUE,NM 87131

[2] SUNY BUFFALO,SCH PHARM,BUFFALO,NY 14260

来源：

AMERICAN JOURNAL OF MEDICINE | 1988年 / 84卷 / 06期

关键词：

D O I：

10.1016/0002-9343(88)90310-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1053 / 1060

页数：8

共 36 条

[1] DRUG DISPOSITION IN OBESE HUMANS - AN UPDATE [J].

ABERNETHY, DR ;

GREENBLATT, DJ .

CLINICAL PHARMACOKINETICS, 1986, 11 (03) :199-213

[2] DIGOXIN DISPOSITION IN OBESITY - CLINICAL PHARMACOKINETIC INVESTIGATION [J].

ABERNETHY, DR ;

GREENBLATT, DJ ;

SMITH, TW .

AMERICAN HEART JOURNAL, 1981, 102 (04) :740-744

[3] INFLUENCE OF WEIGHT ON AMINOGLYCOSIDE PHARMACOKINETICS IN NORMAL WEIGHT AND MORBIDLY OBESE PATIENTS [J].

BAUER, LA ;

EDWARDS, WAD ;

DELLINGER, EP ;

SIMONOWITZ, DA .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (05) :643-647

[4] CIMETIDINE CLEARANCE IN THE OBESE [J].

BAUER, LA ;

WAREINGTRAN, C ;

EDWARDS, WAD ;

RAISYS, V ;

FERRERI, L ;

JACK, R ;

DELLINGER, EP ;

SIMONOWITZ, D .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (04) :425-430

[5]

BLOUIN RA, 1985, CLIN PHARMACY, V4, P70

[6] VANCOMYCIN PHARMACOKINETICS IN NORMAL AND MORBIDLY OBESE SUBJECTS [J].

BLOUIN, RA ;

BAUER, LA ;

MILLER, DD ;

RECORD, KE ;

GRIFFEN, WO .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (04) :575-580

[7] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].

COCKCROFT, DW ;

GAULT, MH .

NEPHRON, 1976, 16 (01) :31-41

[8]

CORCORAN GB, 1987, J PHARMACOL EXP THER, V241, P921

[9]

DETTLI LC, 1974, CLIN PHARMACOL THER, V16, P274

[10] ESTIMATING CREATININE CLEARANCE IN MORBIDLY OBESE PATIENTS [J].

DIONNE, RE ;

BAUER, LA ;

GIBSON, GA ;

GRIFFEN, WO ;

BLOUIN, RA .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (06) :841-844

← 1 2 3 4 →